Quantbot Technologies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quantbot Technologies’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,118	Closed	-$1.29M	–	2051
2023 Q2	$1.29M	Sell	51,118 -4,806	-9%	-$150K	0.08%	364
2023 Q1	$1.8M	Buy	55,924 +45,152	+419%	+$1.41M	0.13%	234
2022 Q4	$199K	Buy	10,772 +5,636	+110%	+$129K	0.01%	903
2022 Q3	$138K	Buy	+5,136	New	+$104K	0.01%	1009
2021 Q4	–	Sell	-89	Closed	-$2K	–	2000
2021 Q3	$2K	Buy	89 +6	+7%	+$171	﹤0.01%	1443
2021 Q2	$2K	Buy	+83	New	+$2.39K	﹤0.01%	1397
2020 Q4	–	Sell	-2,027	Closed	-$50K	–	1762
2020 Q3	$50K	Buy	2,027 +414	+26%	+$10.9K	0.01%	862
2020 Q2	$39K	Sell	1,613 -1,534	-49%	-$30.3K	0.01%	757
2020 Q1	$46K	Buy	+3,147	New	+$65.1K	0.03%	454
2019 Q4	–	Sell	-2,217	Closed	-$28K	–	1656
2019 Q3	$28K	Buy	+2,217	New	+$27.1K	﹤0.01%	1075
2018 Q4	–	Sell	-3,381	Closed	-$84K	–	1482
2018 Q3	$84K	Buy	3,381 +3,206	+1,832%	+$87.2K	0.01%	925
2018 Q2	$4K	Buy	+175	New	+$5.26K	﹤0.01%	1136
2018 Q1	–	Sell	-3,861	Closed	-$138K	–	1568
2017 Q4	$138K	Buy	+3,861	New	+$111K	0.01%	788
2015 Q3	–	Sell	-4,367	Closed	-$139K	–	1463
2015 Q2	$139K	Buy	+4,367	New	+$112K	0.02%	543

Other funds holding RVNC

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantbot Technologies's RVNC Position: Q3 2023 in Review

Quantbot Technologies sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2023, closing a stake of 51,118 shares — an estimated $1.29M sold.

Quantbot Technologies first reported a position in RVNC in Q2 2015 and held it in 14 quarters. The position peaked at $1.8M in Q1 2023. 186 funds tracked by Wall St. Rank hold RVNC as of Q3 2023.

Quantbot Technologies reported no remaining Revance Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
Quantbot Technologies sold 51,118 Revance Therapeutics, Inc. shares in Q3 2023, an estimated $1.29M.
Quantbot Technologies first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 14 quarters.
Quantbot Technologies's Revance Therapeutics, Inc. position peaked at $1.8M in Q1 2023.
186 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.